Clinical Trial Update: Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of etanercept and methotrexate in rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED